Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NTC-801
print preview
bookmark
share with colleague
General Information
Company
Nissan Chemical Industries Ltd.
Description
Oral inhibitor of acetylcholine-activated potassium ion channel (IKACh)
Molecular Target
Potassium channel
Mechanism of Action
K channel blocker
Latest Stage of Development
Phase II
Indication
Fibrillation
Partner
Bristol-Myers Squibb Co.
;
Teijin Pharma Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy